InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Eisele Jeffrey, Vice-Président Exécutif. Insider active across 1 company, notably Apellis Pharmaceuticals, Inc.. Aggregated, 6 reports have been logged. Activity tracked since 22 December 2021. The latest transaction was filed on 28 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
434 shares@ US$38.590.0003% mcap40.0% of flowCommon StockSEC:0001127602-22-002814:0
434 shares@ US$38.590.0003% mcap79.9% of flowCommon StockSEC:0001127602-22-002814
26,051 shares0Common StockSEC:0001127602-22-002061
26,051 shares0Common StockSEC:0001127602-22-002061:0
89 shares@ US$47.820.0001% mcap20.1% of flowCommon StockSEC:0001127602-21-031867
89 shares@ US$47.820.0001% mcap10.0% of flowCommon StockSEC:0001127602-21-031867:0
6 of 6 declarations
About Eisele Jeffrey
Jeffrey Eisele is Executive Vice President and Program Team Lead at Apellis Pharmaceuticals, Inc. He oversees product development initiatives and contributes to the company's overall strategy. His experience in the pharmaceutical industry is essential for Apellis's success.
